Thue Johansen

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes

Bernard Zinman, Athena Philis‐Tsimikas, Bertrand Cariou et al. · Diabetes Care · 2012 · 333 citations · Full text

The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily

Luigi Meneghini, Stephen L. Atkin, Stephen Gough et al. · Diabetes Care · 2013 · 225 citations · Full text

Insulin Degludec in Type 1 Diabetes

Kåre I. Birkeland, Philip Home, Ulrich Wendisch et al. · Diabetes Care · 2011 · 160 citations · Full text

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

Bernard Zinman, Greg Fulcher, Paturi Vishnupriya Rao et al. · The Lancet · 2011 · 131 citations

Diabetes Management, Insulin Degludec, Diabetes +7

The obese Göttingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile.

Thue Johansen, Harald S. Hansen, Bjørn Richelsen et al. · PubMed · 2001 · 95 citations

Nutrition, Metabolic Disorder, Obesity +16